These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27853005)

  • 41. Solid facial edema: treatment failure with oral isotretinoin monotherapy and combination oral isotretinoin and oral steroid therapy.
    Patel AB; Harting MS; Hsu S
    Dermatol Online J; 2008 Jan; 14(1):14. PubMed ID: 18319031
    [No Abstract]   [Full Text] [Related]  

  • 42. A pharmacokinetic model of the gastrointestinal tract consisting of two segments can describe the concentration-time course of itraconazole.
    Lohitnavy M; Lu Y; Lohitnavy O
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):394-6. PubMed ID: 16961171
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of patients with rubromycosis using collodium bandages].
    Sheklakov ND; Rukavishnikova VM; Kukoleva LI; Trofimova EM
    Vestn Dermatol Venerol; 1977 Jun; (6):69-72. PubMed ID: 883413
    [No Abstract]   [Full Text] [Related]  

  • 44. [First autochthonous case report of tinea nigra in Chile].
    Arellano J; Vargas P; Urrutia M
    Medwave; 2019 Jul; 19(6):e7666. PubMed ID: 31348769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Administration of Oral Itraconazole Capsule with Whole Milk Shows Enhanced Efficacy As Supported by Scanning Electron Microscopy in a Child with Tinea Capitis Due to Microsporum canis.
    Chen S; Ran Y; Dai Y; Lama J; Hu W; Zhang C
    Pediatr Dermatol; 2015; 32(6):e312-3. PubMed ID: 26447934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
    Otani H; Inoue K; Shiota T; Suzuki Y; Nomura S; Harada Y; Ishibashi H; Abe S; Uchida K; Yamaguchi H; Torii S
    Nihon Yakurigaku Zasshi; 2007 Jul; 130(1):69-76. PubMed ID: 17634684
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling.
    Raza K; Singh B; Singla S; Wadhwa S; Garg B; Chhibber S; Katare OP
    Mol Pharm; 2013 May; 10(5):1958-63. PubMed ID: 23544848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
    Lin HS; Leong WW; Yang JA; Lee P; Chan SY; Ho PC
    Int J Pharm; 2007 Aug; 341(1-2):238-45. PubMed ID: 17482391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Folliculitis spinulosa decalvans: failure to respond to oral isotretinoin.
    Hallai N; Thompson I; Williams P; Anstey AV
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):223-4. PubMed ID: 16441642
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment.
    Hasibur MR; Meraj Z
    Mymensingh Med J; 2013 Jan; 22(1):42-8. PubMed ID: 23416807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of oral itraconazole administration in captive Humboldt penguins (Spheniscus humboldti).
    Bunting EM; Abou-Madi N; Cox S; Martin-Jimenez T; Fox H; Kollias GV
    J Zoo Wildl Med; 2009 Sep; 40(3):508-18. PubMed ID: 19746867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Folliculitis decalvans of the scalp: response to triple therapy with isotretinoin, clindamycin, and prednisolone.
    Gemmeke A; Wollina U
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):184-6. PubMed ID: 17982613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral isotretinoin for the treatment of chronic pityriasis versicolor: case report and literature review.
    Veasey JV; Carvalho GSM; Valinoto GCJ
    An Bras Dermatol; 2024; 99(4):639-642. PubMed ID: 38670865
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
    Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Itraconazole in the treatment of tinea capitis.
    Degreef H
    Cutis; 1996 Jul; 58(1):90-3. PubMed ID: 8823558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavir.
    Hills-Nieminen C; Hughes CA; Houston S; Shafran SD
    Ann Pharmacother; 2009 Dec; 43(12):2117-20. PubMed ID: 19934385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
    Lee JH; Shin JH; Lee MG
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.